2 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Terminated 2 |
Follow Idiopathic Interstitial Pneumonias: new trials by email Literature Review of Idiopathic Interstitial Pneumonias trials Research Report on Idiopathic Interstitial Pneumonias
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) Pamrevlumab, Placebo - Idiopathic Pulmonary Fibrosis | Phase 3 | Terminated | Kyntra Bio | 372 | 2020-09-30 | 2024-08-12 |
| Zephyrus I: Evaluation of Efficacy and Safety of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) Pamrevlumab, Placebo - Idiopathic Pulmonary Fibrosis | Phase 3 | Terminated | Kyntra Bio | 393 | 2019-06-18 | 2024-09-19 |
Idiopathic Pulmonary Fibrosis (2) · Lung Diseases, Interstitial (2) · Pulmonary Fibrosis (2)
Fibrosis (2) · Lung Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Respiratory Tract Diseases (2)
pamrevlumab (2)
Kyntra Bio (2)
Argentina (2) · China (2) · South Korea (2) · United States (2) · Australia (1) · Brazil (1) · Chile (1) · Colombia (1) · Czechia (1) · Denmark (1) · Dominican Republic (1) · France (1) · Georgia (1) · Germany (1) · Hong Kong (1)